Diabetes Self-Management Blog

Potential A1C Test Alternative
According to a new study published in the journal The Lancet Diabetes & Endocrinology, measurements of substances known as fructosamine and glycated albumin might be useful for predicting a person’s risk of developing diabetes complications.

The A1C test measures blood glucose control over the previous 2–3 months, but the results of the test are not valid in people with conditions such as anemia, kidney disease, hemoglobinopathies, and HIV. To determine whether fructosamine and glycated albumin, markers of glucose control over 2–4 weeks, might be useful for predicting diabetes complications in these populations, researchers took blood samples from over 12,000 people in the Atherosclerosis Risk in Communities (ARIC) Study.

“We compared the associations of [A1C], fructosamine, and glycated albumin with two of the most important clinical outcomes related to diabetes: retinopathy (eye disease) and kidney disease. We found that fructosamine and glycated albumin were strongly associated with retinopathy and kidney disease. [T]hese associations were similar to those observed for [A1C] with these outcomes,” noted lead study author Elizabeth Selvin, PhD, MPH.

According to the researchers, these results suggest that fructosamine and glycated albumin may be useful alternatives for monitoring long-term blood glucose control in people for whom the A1C test is invalid. “Further studies are need to understand the value of these tests in the clinic,” said Selvin.

For more information, read the press release from Johns Hopkins Bloomberg School of Public Health or see the study’s abstract in the journal The Lancet Diabetes & Endocrinology. And to learn more about the A1C test, click here.

Glucose Meter Recall
Nipro Diagnostics has launched a voluntary recall and replacement of several hundred blood glucose meters that incorrectly display results in mmol/L, rather than the correct mg/dl measure. This incorrect, factory-set unit of measure can cause users to misread their results as lower than expected.

The recall involves 501 TRUEbalance meters and 105 TRUEtrack meters distributed in the United States between September 2008 and May 2013. Consumers using either of these brands of meter are encouraged to obtain their meter’s serial number from the back of the device and contact Nipro Diagnostics here or Stericycle at (866) 236-4518 to determine whether their meter is affected by the recall.

Replacement meters will be provided to customers at no charge, according to Nipro.

For more information, click here.


  1. There are no comments at this time.

Post a Comment

Note: All comments are moderated and there may be a delay in the publication of your comment. Please be on-topic and appropriate. Do not disclose personal information. Be respectful of other posters. Only post information that is correct and true to your knowledge. When referencing information that is not based on personal experience, please provide links to your sources. All commenters are considered to be nonmedical professionals unless explicitly stated otherwise. Promotion of your own or someone else's business or competing site is not allowed: Sharing links to sites that are relevant to the topic at hand is permitted, but advertising is not. Once submitted, comments cannot be modified or deleted by their authors. Comments that don't follow the guidelines above may be deleted without warning. Such actions are at the sole discretion of DiabetesSelfManagement.com. Comments are moderated Monday through Friday by the editors of DiabetesSelfManagement.com. The moderators are employees of Madavor Media, LLC., and do not report any conflicts of interest. A privacy policy setting forth our policies regarding the collection, use, and disclosure of certain information relating to you and your use of this Web site can be found here. For more information, please read our Terms and Conditions.

Tools & Technology
Children With Diabetes "Focus on Technology" Conference (07/28/14)
Bionic Pancreas Trials Currently Recruiting (07/03/14)
Technology Is Amazing… So Are We (06/27/14)
Researchers Successfully Test "Bionic Pancreas" (06/26/14)

Diabetes Research
New Approach for Neuropathy Pain? (08/18/14)
Metformin Study Currently Recruiting (08/19/14)
FDA Approves New Oral Drug for Type 2 Diabetes (08/07/14)
Shift Work Tied to Increased Type 2 Diabetes Risk (07/31/14)

Diabetes News
New Approach for Neuropathy Pain? (08/18/14)
FDA Approves New Oral Drug for Type 2 Diabetes (08/07/14)
Shift Work Tied to Increased Type 2 Diabetes Risk (07/31/14)
High-Salt Diet Doubles Heart Risk in Type 2 Diabetes (07/25/14)

Blood Glucose Monitoring
Blood Glucose Monitoring: Minimize the Pain, Maximize the Gain (08/15/14)
Why Do Test Strips Cost So Much? (Part 2) (09/25/13)
Why Do Test Strips Cost So Much? (09/24/13)

Diane Fennell
New Approach for Neuropathy Pain? (08/18/14)
New Metformin Combo Drug Approved for Type 2 Diabetes (08/13/14)
FDA Approves New Oral Drug for Type 2 Diabetes (08/07/14)
Shift Work Tied to Increased Type 2 Diabetes Risk (07/31/14)



Disclaimer of Medical Advice: You understand that the blog posts and comments to such blog posts (whether posted by us, our agents or bloggers, or by users) do not constitute medical advice or recommendation of any kind, and you should not rely on any information contained in such posts or comments to replace consultations with your qualified health care professionals to meet your individual needs. The opinions and other information contained in the blog posts and comments do not reflect the opinions or positions of the Site Proprietor.